Stephen Mayo is a director of Allogene Therapeutics Inc.
Person profile
Roles
Address
Kenilworth, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sarepta Therapeutics, Inc.
6 Mar 24
4
Sarepta Therapeutics, Inc.
5 Mar 24
144
Sarepta Therapeutics, Inc.
5 Mar 24
4
Allogene Therapeutics, Inc.
9 Aug 23
144
Allogene Therapeutics, Inc.
7 Aug 23
4
Allogene Therapeutics, Inc.
15 Jun 23
4
Merck & Co., Inc.
31 May 23
4
Sarepta Therapeutics, Inc.
8 Mar 23
4
Sarepta Therapeutics, Inc.
21 Nov 22
4
Allogene Therapeutics, Inc.
12 Jul 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Mar 24 | SRPT Sarepta Therapeutics | Common Stock | Sell | Dispose S | No | No | 122.96 | 3,135 | 385.48 k | 6,621 |
1 Mar 24 | SRPT Sarepta Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 1,846 | 0.00 | 9,756 |
1 Mar 24 | SRPT Sarepta Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 128.67 | 3,679 | 473.38 k | 3,679 |
7 Aug 23 | ALLO Allogene Therapeutics | Common Stock | Sell | Dispose S | No | No | 4.2855 | 10,000 | 42.86 k | 25,328 |
13 Jun 23 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.7 | 116,120 | 661.88 k | 116,120 |
26 May 23 | MRK Merck & Co | Phantom Stock Common Stock | Grant | Acquire A | No | No | 111.07 | 1,980.733 | 220.00 k | 7,430.36 |